These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 2271375)

  • 1. Propranolol oxidation by human liver microsomes--the use of cumene hydroperoxide to probe isoenzyme specificity and regio- and stereoselectivity.
    Otton SV; Gillam EM; Lennard MS; Tucker GT; Woods HF
    Br J Clin Pharmacol; 1990 Nov; 30(5):751-60. PubMed ID: 2271375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of human CYP isoforms involved in the metabolism of propranolol enantiomers--N-desisopropylation is mediated mainly by CYP1A2.
    Yoshimoto K; Echizen H; Chiba K; Tani M; Ishizaki T
    Br J Clin Pharmacol; 1995 Apr; 39(4):421-31. PubMed ID: 7640150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propranolol hydroxylation and N-desisopropylation by cytochrome P4502D6: studies using the yeast-expressed enzyme and NADPH/O2 and cumene hydroperoxide-supported reactions.
    Bichara N; Ching MS; Blake CL; Ghabrial H; Smallwood RA
    Drug Metab Dispos; 1996 Jan; 24(1):112-8. PubMed ID: 8825198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Species difference in enantioselectivity for the oxidation of propranolol by cytochrome P450 2D enzymes.
    Narimatsu S; Kobayashi N; Masubuchi Y; Horie T; Kakegawa T; Kobayashi H; Hardwick JP; Gonzalez FJ; Shimada N; Ohmori S; Kitada M; Asaoka K; Kataoka H; Yamamoto S; Satoh T
    Chem Biol Interact; 2000 Jun; 127(1):73-90. PubMed ID: 10903420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regio- and stereoselectivity in propranolol metabolism by dog liver microsomes and the expressed dog CYP2D15.
    Tasaki T; Iwata H; Kazusaka A; Fujita S
    J Biochem; 1998 Apr; 123(4):747-51. PubMed ID: 9538270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substrate stereoselectivity and enantiomer/enantiomer interaction in propranolol metabolism in rat liver microsomes.
    Masubuchi Y; Yamamoto LA; Uesaka M; Fujita S; Narimatsu S; Suzuki T
    Biochem Pharmacol; 1993 Nov; 46(10):1759-65. PubMed ID: 8250961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450 isozymes involved in propranolol metabolism in human liver microsomes. The role of CYP2D6 as ring-hydroxylase and CYP1A2 as N-desisopropylase.
    Masubuchi Y; Hosokawa S; Horie T; Suzuki T; Ohmori S; Kitada M; Narimatsu S
    Drug Metab Dispos; 1994; 22(6):909-15. PubMed ID: 7895609
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidation of (R)- and (S)-propranolol in human and dog liver microsomes. Species differences in stereoselectivity.
    von Bahr C; Hermansson J; Lind M
    J Pharmacol Exp Ther; 1982 Aug; 222(2):458-62. PubMed ID: 7097564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes.
    Masubuchi Y; Kagimoto N; Narimatsu S; Fujita S; Suzuki T
    Drug Metab Dispos; 1993; 21(6):1012-6. PubMed ID: 7905378
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regio- and stereoselective propranolol metabolism by 15 forms of purified cytochromes P-450 from rat liver.
    Fujita S; Umeda S; Funae Y; Imaoka S; Abe H; Ishida R; Adachi T; Masuda M; Kazusaka A; Suzuki T
    J Pharmacol Exp Ther; 1993 Jan; 264(1):226-33. PubMed ID: 8423527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation.
    Meyer UA; Gut J; Kronbach T; Skoda C; Meier UT; Catin T; Dayer P
    Xenobiotica; 1986 May; 16(5):449-64. PubMed ID: 2874666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic kinetics of pseudoracemic propranolol in human liver microsomes. Enantioselectivity and quinidine inhibition.
    Marathe PH; Shen DD; Nelson WL
    Drug Metab Dispos; 1994; 22(2):237-47. PubMed ID: 8013280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regio- and stereoselective oxidation of propranolol enantiomers by human CYP2D6, cynomolgus monkey CYP2D17 and marmoset CYP2D19.
    Narimatsu S; Nakata T; Shimizudani T; Nagaoka K; Nakura H; Masuda K; Katsu T; Koeda A; Naito S; Yamano S; Miyata A; Hanioka N
    Chem Biol Interact; 2011 Feb; 189(3):146-52. PubMed ID: 21184751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytochrome P450 isozymes involved in aromatic hydroxylation and side-chain N-desisopropylation of alprenolol in rat liver microsomes.
    Narimatsu S; Tachibana M; Masubuchi Y; Imaoka S; Funae Y; Suzuki T
    Biol Pharm Bull; 1995 Aug; 18(8):1060-5. PubMed ID: 8535396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (S)-4'-hydroxypropranolol causes product inhibition and dose-dependent bioavailability of propranolol enantiomers in the isolated perfused rat liver and in rat liver microsomes.
    Nand RA; Ghabrial H; Smallwood RA; Morgan DJ
    Xenobiotica; 1996 Dec; 26(12):1249-61. PubMed ID: 9004455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variable contribution of CYP2D6 to the N-dealkylation of S-(-)-propranolol by human liver microsomes.
    Rowland K; Ellis SW; Lennard MS; Tucker GT
    Br J Clin Pharmacol; 1996 Sep; 42(3):390-3. PubMed ID: 8877032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidation of R- and S-omeprazole stereoselectively mediated by liver microsomal cytochrome P450 2C19 enzymes from cynomolgus monkeys and common marmosets.
    Uehara S; Kawano M; Murayama N; Uno Y; Utoh M; Inoue T; Sasaki E; Yamazaki H
    Biochem Pharmacol; 2016 Nov; 120():56-62. PubMed ID: 27641812
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs.
    Koyama E; Chiba K; Tani M; Ishizaki T
    J Pharmacol Exp Ther; 1997 Jun; 281(3):1199-210. PubMed ID: 9190854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of CYP2D6 activity by treatment with propranolol and the role of 4-hydroxy propranolol.
    Rowland K; Yeo WW; Ellis SW; Chadwick IG; Haq I; Lennard MS; Jackson PR; Ramsay LE; Tucker GT
    Br J Clin Pharmacol; 1994 Jul; 38(1):9-14. PubMed ID: 7946944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective hydroxylation of mexiletine in human liver microsomes: implication of P450IID6--a preliminary report.
    Vandamme N; Broly F; Libersa C; Courseau C; Lhermitte M
    J Cardiovasc Pharmacol; 1993 Jan; 21(1):77-83. PubMed ID: 7678683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.